share_log

Inozyme Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pivotal Partners Ltd(9.5%),Pivotal Life Sciences Holdings Limited(9.5%), etc.

Inozyme Pharma | SC 13D/A:超过5%持股股东披露文件(修正)-Pivotal Partners Ltd(9.5%),Pivotal Life Sciences Holdings Limited(9.5%)等

SEC announcement ·  2023/08/07 21:58
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息